Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children

被引:40
|
作者
Kondo, M
Kojima, S
Horibe, K
Kato, K
Matsuyama, T
机构
[1] Okazaki City Hosp, Dept Pediat, Okazaki, Aichi 4448553, Japan
[2] Nagoya Univ, Sch Med, Dept Pediat, Nagoya, Aichi 466, Japan
[3] Nagoya First Hosp, Japanese Red Cross, Childrens Med Ctr, Div Hematol Oncol, Nagoya, Aichi, Japan
关键词
chronic GVHD; stem cell transplantation; risk factor; children;
D O I
10.1038/sj.bmt.1702868
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We analyzed the incidence and risk factors for chronic graft-versus-host disease (GVHD) in 265 children undergoing allogeneic stem cell transplantation (SCT) who survived longer than 3 months post SCT, Patients transplanted from HLA-mismatched related donors and matched unrelated donors were included. Fifty-five patients developed chronic GVHD between 1 and 25 months after SCT, and the 5-year cumurative incidence of chronic GVHD was 22%. By multivariate analysis, acute GVHD (P = 0.004), malignant disease (P = 0.004), recipient age ((greater than or equal to 10 years) (P = 0.01) and a female donor to male recipient (P = 0.035) were significant risk factors for chronic GVHD. When acute GVHD was excluded from the multivariate analysis, malignant disease (P = 0.002) and older recipient age (P = 0.007) were identified. The incidence of chronic GVHD in this childhood study was lower than that observed in adults, and recipient age was an important factor in childhood SCT, The high incidence associated with malignant disease may be affected by changes in GVHD prophylaxis in order to ensure graft-versus-tumor effects.
引用
收藏
页码:727 / 730
页数:4
相关论文
共 50 条
  • [21] Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation
    Stratton, Pamela
    Turner, Maria L.
    Childs, Richard
    Barrett, John
    Bishop, Michael
    Wayne, Alan S.
    Pavletic, Steven
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (05): : 1041 - 1049
  • [22] Graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in children and adolescents with thalassemia
    Pakakasama, S.
    Klamchuen, S.
    Hongeng, S.
    Sirireung, S.
    Anurathapan, U.
    Songdej, D.
    Sasinil, S.
    Sirachainan, N.
    Chuansumrit, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S285 - S285
  • [23] Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Heston, Sarah M.
    Jenkins, Kirsten
    Spees, Lisa
    Sung, Anthony D.
    Corbet, Kelly
    Thompson, Jillian C.
    Bohannon, Lauren
    Martin, Paul L.
    Stokhuyzen, Andre
    Vinesett, Richard
    Ward, Doyle, V
    Bhattarai, Shakti K.
    Bucci, Vanni
    Arshad, Mehreen
    Seed, Patrick C.
    Kelly, Matthew S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2053 - 2060
  • [24] Anaerobic Antibiotics and the Risk of Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Tanaka, John
    Young, Rebecca
    Spees, Lisa
    Jenkins, Kirsten
    Sung, Anthony D.
    Martin, Paul L.
    Heston, Sarah
    Thompson, Jillian C.
    Seed, Patrick
    Arshad, Mehreen
    Kelly, Matthew
    BLOOD, 2019, 134
  • [25] Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?
    Koc, H
    Gurman, G
    Arslan, O
    Ozcan, M
    Akan, H
    Ilhan, O
    Konuk, N
    Beksac, M
    Uysal, A
    BLOOD, 1996, 88 (06) : 2362 - 2364
  • [26] Incidence, risk factors and clinical outcome of chronic graft-versus-host disease in children given allogeneic hematopoietic stem cell transplantation.
    Zecca, M
    Prete, A
    Rondelli, R
    Lanino, E
    Balduzzi, A
    Messina, C
    Fagioli, F
    Porta, F
    Pession, A
    Locatelli, F
    BLOOD, 2001, 98 (11) : 740A - 740A
  • [27] Prevalence of genital graft-versus-host disease after allogeneic stem cell transplantation
    Knutsson, E. Smith
    Broman, A-K.
    Bjork, Y.
    Hallberg, D.
    Helstrom, L.
    Nilsson, O.
    Sundfeldt, K.
    Styrenius, M.
    Brune, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S127 - S127
  • [28] Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease
    Robak, Katarzyna
    Zambonelli, Joanna
    Bilinski, Jaroslaw
    Basak, Grzegorz W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (05) : 495 - 502
  • [29] Chronic graft-versus-host disease: risk factors and impact on long-term outcome after allogeneic haematopoietic stem cell transplantation
    Wojnar, J
    Giebel, S
    Krawczyk-Kulis, M
    Markiewicz, M
    Wylezol, I
    Kruzel, T
    Stella-Holowiecka, B
    Nowak, K
    Kopera, M
    Czerw, T
    Holowiecki, J
    BONE MARROW TRANSPLANTATION, 2006, 37 : S100 - S100
  • [30] Significance of prognostic scores, risk factors and chronic graft-versus-host disease on outcome after allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Ditschkowski, M.
    Emlaagacli, A.
    Trenschel, R.
    Steckel, N.
    Gromke, T.
    Koldehoff, M.
    Beelen, D.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S433 - S433